Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19
Abstract Cancer patients are more susceptible to SARS-CoV-2 infection and generally have higher mortality rate. Anti-SARS-CoV-2 IgG is an important consideration for the patients in this COVID-19 pandemic. Recent researches suggested the rapid decay of anti-SARS-CoV-2 antibodies in the general popul...
Enregistré dans:
| Auteurs principaux: | Yongsheng Huang, Jing Yu, Dan Li, Kai He, Wenyang Liu, Lin Wang, Yeshan Chen, Conghua Xie, Xiaowei Wu |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/2bf4547a9fc44aaab5e7dcaaaeccfa1a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Discrete SARS-CoV-2 antibody titers track with functional humoral stability
par: Yannic C. Bartsch, et autres
Publié: (2021) -
Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history
par: Thomas W. McDade, et autres
Publié: (2021) -
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
par: Ramon Roozendaal, et autres
Publié: (2021) -
Case series: Reinfection of recovered SARS CoV‐2 patients for the third time
par: Sepideh Hasanzadeh, et autres
Publié: (2021) -
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
par: Kening Li, et autres
Publié: (2020)